Atticus Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Atticus Wealth Management, LLC

$285 Million
Q3 2024

A detailed history of Atticus Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atticus Wealth Management, LLC holds 1,005 shares of BMY stock, worth $53,455. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,005

Previous 1,266 20.62%

Holding current value

$53,455

Previous $52,000 -0.0%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$39.66 - $51.75 $10,351 - $13,506	-261 Reduced 20.62%	1,005 $52,000
Q2 2024 Jul 17, 2024	SELL	$40.25 - $52.99 $62,387 - $82,134	-1,550 Reduced 55.04%	1,266 $52,000
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $82,669 - $93,731	-1,723 Reduced 37.96%	2,816 $152,000
Q4 2023 Jan 17, 2024	BUY	$48.48 - $57.85 $64,672 - $77,171	1,334 Added 41.62%	4,539 $232,000
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $27,208 - $30,423	-470 Reduced 12.79%	3,205 $186,000
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $8,154 - $9,054	-128 Reduced 3.37%	3,675 $235,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $46,391 - $52,618	706 Added 22.8%	3,803 $263,000
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $12,668 - $15,001	-185 Reduced 5.64%	3,097 $222,000
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $229,914 - $253,216	3,166 Added 2729.31%	3,282 $253,000
Q1 2022 Apr 15, 2022	SELL	$61.48 - $73.72 $48,200 - $57,796	-784 Reduced 87.11%	116 $8,000
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $48,267 - $56,268	900 New	900 $56,000
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $117,038 - $137,095	-1,978 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $619 - $674	-10 Reduced 0.5%	1,978 $132,000
Q1 2021 Apr 15, 2021	SELL	$59.34 - $66.74 $13,707 - $15,416	-231 Reduced 10.41%	1,988 $125,000
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $288 - $327	5 Added 0.23%	2,219 $138,000
Q3 2020 Oct 21, 2020	SELL	$57.43 - $63.64 $28,887 - $32,010	-503 Reduced 18.51%	2,214 $134,000
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $30,644 - $35,826	-559 Reduced 17.06%	2,717 $160,000
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $29,835 - $43,357	-643 Reduced 16.41%	3,276 $183,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $192,853 - $251,560	3,919 New	3,919 $252,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atticus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atticus Wealth Management, LLC with notifications on news.

Account

Atticus Wealth Management, LLC Bristol Myers Squibb CO Transaction History